🇺🇸 FDA
Patent

US 10676527

Methods and compositions for modulation of blood-neural barrier

granted A61KA61K2039/505A61K31/00

Quick answer

US patent 10676527 (Methods and compositions for modulation of blood-neural barrier) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K31/00, A61K38/43, A61K39/39533